Optimal clinical risk prediction can be achieved by combining quantitative fetal fibronectin and cervical length, and avoiding thresholds
Acta Obstet Gynecol Scand
.
2016 Aug;95(8):956.
doi: 10.1111/aogs.12922.
Epub 2016 Jun 7.
Authors
Georgia N Ross
1
,
Alexandra E Ridout
2
,
Andrew H Shennan
2
Affiliations
1
Faculty of Health and Medicine, University of Newcastle, Callaghan, NSW, Australia.
2
Division of Women's Health, King's College London, St Thomas' Hospital, London, UK.
PMID:
27198928
DOI:
10.1111/aogs.12922
No abstract available
Publication types
Letter
Comment
MeSH terms
Cervical Length Measurement*
Cervix Uteri
Fibronectins*
Humans
Obstetric Labor, Premature
Predictive Value of Tests
Prospective Studies
Risk
Substances
Fibronectins